ID   Ca9-22SF
AC   CVCL_HM41
SY   Ca9-22 SF; Ca 9-22 SF; Ca9-22 Serum Free
DR   cancercelllines; CVCL_HM41
DR   Wikidata; Q54808307
RX   DOI=10.5794/jjoms.31.264;
RX   DOI=10.5794/jjoms.31.273;
RX   PubMed=2228902;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 18 hours (DOI=10.5794/jjoms.31.264).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1102 ! Ca9-22
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 13
//
RX   DOI=10.5794/jjoms.31.264;
RA   Rikimaru K.;
RT   "Establishment of a human gingival carcinoma cell line growing in a
RT   serum-free medium and studies on its application. 1. Establishment of
RT   human gingival carcinoma cell line (Ca 9-22 SF) growing in serum-free
RT   medium.";
RL   Nihon Koku Geka Gakkai Zasshi 31:264-272(1985).
//
RX   DOI=10.5794/jjoms.31.273;
RA   Rikimaru K.;
RT   "Establishment of a human gingival carcinoma cell line growing in a
RT   serum-free medium and studies on its application. 2. Studies on
RT   effects of growth factors on the serum-free cultured cell line (Ca 9-22
RT   SF) derived from the human gingival carcinoma.";
RL   Nihon Koku Geka Gakkai Zasshi 31:273-279(1985).
//
RX   PubMed=2228902; DOI=10.1007/BF02624609;
RA   Rikimaru K., Toda H., Tachikawa N., Kamata N., Enomoto S.;
RT   "Growth of the malignant and nonmalignant human squamous cells in a
RT   protein-free defined medium.";
RL   In Vitro Cell. Dev. Biol. 26:849-856(1990).
//